In recent years certain aliphatic and
carbocyclic adenosine analogues have been developed which are of potential clinical importance as
antiviral agents. This includes
(S)-9-(2,3-dihydroxypropyl)adenine [(
S)-DHPA] and
carbocyclic 3-deazaadenosine (C-c3Ado). (
S)-DHPA and C-c3Ado are remarkably similar in their
antiviral spectrum in that they are particularly active against (-) RNA viruses such as
measles, para-
influenza, respiratory syncytial virus, rabies virus,
vesicular stomatitis virus and (+/-)RNA viruses such as reo- and rotavirus, whereas (+)RNA viruses such as
polio, coxsackie and (+/-)DNA viruses such as
herpes simplex are only minimally affected or not inhibited at all. In contrast with (
S)-DHPA and C-c3Ado which are quite selective in their
antiviral action, other
adenosine analogues, i.e.,
3-deazaadenosine and
7-deazaadenosine (
tubercidin), exhibit little, if any, selectivity as
antiviral agents. Also,
tubercidin has a broader activity spectrum, encompassing (+)RNA viruses as well as
herpes simplex in addition to the (-)RNA viruses. Considering the high
antiviral potency of
tubercidin, attempts have been undertaken to increase its selectivity, i.e., by chemical substitutions at C-5 of the
pyrrolo(2,3-d)pyrimidine ring. These attempts have been partially successful.